David R. Epstein, Director at Rubius Therapeutics, Inc. (RUBY), sold 195,374 shares at $14.79 ($2.9M) on 2021-02-10, disclosed to the SEC on 2021-02-10.
Open-market sale of $2.9M RUBY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.88 | 89,233 | $1.3M | 45.7% |
| 2 | $14.88 | 89,233 | $1.3M | 45.7% |
| 3 | $14.83 | 2,100 | $31K | 1.1% |
| 4 | $14.79 | 7,404 | $110K | 3.8% |
| 5 | $14.79 | 7,404 | $110K | 3.8% |
| Total | $14.87 avg | 195,374 |
| $2.9M |
| 100% |
| Filing → |
| TEM | SELL | 2026-06-03 | $12K | — | Filing → |
| TEM | SELL | 2026-03-04 | $13K | — | Filing → |
| TEM | SELL | 2026-02-04 | $22K | — | Filing → |